Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.590
-0.030 (-1.85%)
Nov 22, 2024, 4:00 PM EST - Market closed
Entera Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 59 | 17 | 21 | 81 | 20 | 26 | |
Market Cap Growth | 230.38% | -17.80% | -74.04% | 308.59% | -23.75% | -25.38% | |
Enterprise Value | 52 | 10 | 7 | 54 | 13 | 20 | |
Last Close Price | 1.59 | 0.60 | 0.73 | 2.81 | 1.08 | 2.14 | |
PS Ratio | 697.14 | - | 156.95 | 141.91 | 54.33 | 110.21 | |
PB Ratio | 9.00 | 1.66 | 1.79 | 3.59 | 2.64 | 2.18 | |
P/TBV Ratio | 10.70 | 1.66 | 1.79 | 3.59 | 2.64 | 2.30 | |
EV/Sales Ratio | 524.82 | - | 51.05 | 94.51 | 35.56 | 86.57 | |
Debt / Equity Ratio | 0.05 | 0.04 | 0.01 | 0.01 | 0.06 | 0.03 | |
Asset Turnover | 0.01 | - | 0.01 | 0.03 | 0.03 | 0.02 | |
Quick Ratio | 6.26 | 10.10 | 9.36 | 7.93 | 4.81 | 3.37 | |
Current Ratio | 6.61 | 10.32 | 9.58 | 8.01 | 4.95 | 3.41 | |
Return on Equity (ROE) | -144.67% | -80.30% | -76.17% | -81.04% | -115.46% | -97.98% | |
Return on Assets (ROA) | -70.61% | -44.65% | -43.06% | -42.77% | -52.83% | -47.66% | |
Return on Capital (ROIC) | -85.93% | -49.13% | -48.52% | -49.57% | -69.25% | -64.11% | |
Earnings Yield | -15.67% | -51.42% | -62.15% | -15.04% | -56.56% | -41.50% | |
FCF Yield | -13.61% | -42.38% | -59.65% | -11.21% | -53.50% | -34.45% | |
Buyback Yield / Dilution | -22.42% | -0.69% | -10.23% | -41.90% | -51.62% | -52.15% | |
Total Shareholder Return | -22.42% | -0.69% | -10.23% | -41.90% | -51.62% | -52.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.